CompletedPhase 1

Intraumbilical Misoprostol in Retained Placenta

Iraq46 participantsStarted 2011-04

Plain-language summary

Administration of intraumbilical misoprostol to women with retained placenta despite active management of third stage of labour reduces the need for manual removal of placenta and the amount of blood loss vaginally.

Who can participate

Age range15 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * women having singleton pregnancy * 28 weeks of gestation or more delivered vaginally * prolongation of the third stage of labour (more than 30 min) following active management of third stage of labour Exclusion Criteria: * Who refused to participate in the trial * Multiple pregnancies * Previous Caesarean Section * Haemodynamically unstable * Severe anaemia (haemoglobin less than 8gm/dl) * Chorioamnionitis

What they're measuring

delivery of placenta by medical intervention

Timeframe: 30 minutes after the injection of misoprostol or normal saline in the umbilical vein

Trial details

NCT IDNCT01840813

SponsorHawler Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-03

View on ClinicalTrials.gov More Retained Placenta trials